Efficacity of Gefitinib or Erlotinib for EGFR- mutant advanced non-small cell lung carcinoma. (2022). Latakia University Journal -Medical Sciences Series, 43(6), 25-32. https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/11534